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Abstract
The role of aquaporins in cerebrospinal fluid (CSF) secretion was investigated in this study. Western analysis and immunocytochemistry
were used to examine the expression of aquaporin 1 (AQP1) and aquaporin 4 (AQP4) in the rat choroid plexus epithelium. Western analyses
were performed on a membrane fraction that was enriched in Na+/K+-ATPase and AE2, marker proteins for the apical and basolateral
membranes of the choroid plexus epithelium, respectively. The AQP1 antibody detected peptides with molecular masses of 27 and 32 kDa in
fourth and lateral ventricle choroid plexus. A single peptide of 29 kDa was identified by the AQP4 antibody in fourth and lateral ventricle
choroid plexus. Immunocytochemistry demonstrated that AQP1 is expressed in the apical membrane of both lateral and fourth ventricle
choroid plexus epithelial cells. The immunofluorescence signal with the AQP4 antibody was diffusely distributed throughout the cytoplasm,
and there was no evidence for AQP4 expression in either the apical or basolateral membrane of the epithelial cells. The data suggest that
AQP1 contributes to water transport across the apical membrane of the choroid plexus epithelium during CSF secretion. The route by which
water crosses the basolateral membrane, however, remains to be determined.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Choroid plexus epithelial cells are responsible for secret-
ing the majority of cerebrospinal fluid (CSF) into the
ventricles of the brain [1,2]. The process of CSF secretion
involves the carefully regulated transport of Na+, Cl and
HCO3
 from the blood to the ventricles, creating the osmotic
gradient that drives the secretion of water. Many of the
membrane transport proteins involved in ion transport
across the choroid plexus epithelium have now been iden-
tified [2]. Less is known, however, about the route by which
water is transported into the CSF [2].
In many epithelia, the aquaporins (AQP), a family of
water channel proteins, play a major role in water transport
[3,4]. Soon after the identification and isolation of aqua-
porin 1 (AQP1) from erythrocytes, Nielsen et al. [5]
demonstrated that AQP1 was expressed in the apical
(CSF-facing) membrane of rat fourth ventricle choroid
plexus epithelium. The expression of AQP1 in the apical
membrane of choroid plexus epithelial cells was also
observed by Wu et al. [6] and Masseguin et al. [7]. These
data suggest that water transport across the choroid plexus
epithelium is transcellular, with AQP1 contributing to trans-
port from the cell into the CSF across the apical membrane.
The route by which water enters the cell at the basolateral
(blood-facing) membrane, however, remains to be deter-
mined.
Aquaporin 4 (AQP4) is expressed in the basolateral
membrane of many epithelia, e.g. kidney collecting duct,
colon and trachea [3,8]. AQP4 is also widely expressed
throughout the central nervous system [9,10], and is
expressed in the basolateral membrane of the ependymal
cells that line the ventricles [8]. Thus, AQP4 is a likely
candidate for the water transport pathway in the basolateral
membrane of the choroid plexus epithelium. There are,
however, conflicting reports on AQP4 expression in the
choroid plexus. Hasegawa et al. [11] failed to detect AQP4
mRNA using in situ hybridisation in fourth ventricle cho-
roid plexus. Immunocytochemical studies also failed to
detect AQP4 in rat choroid plexus [8,12]. By contrast, a
recent in situ hybridisation study demonstrated the expres-
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sion of mRNA encoding for AQP4 in the epithelial cells of
rat lateral ventricle choroid plexus [13].
The aim of the present study was to examine AQP4
expression in fourth and lateral ventricle choroid plexus
using western analysis and immunocytochemistry. To per-
form the western analysis, a method was developed for the
isolation of a membrane fraction containing both apical and
basolateral membrane proteins. The data obtained show that
AQP4 is expressed in fourth and lateral ventricle choroid
plexus, but does not appear to be expressed in the basolateral
membrane of the epithelial cells. A preliminary account of
some of these data has been published as an abstract [14].
2. Methods
2.1. Animals and tissue collection
Adult Sprague–Dawley rats were killed by an overdose
of halothane (Zeneca Laboratories, UK), and the choroid
plexuses removed from the fourth and lateral ventricles of
the brain. Tissue samples were then either: (i) snap-frozen in
liquid N2 for use in western analysis, or (ii) placed in fixative
for 30 min for immunofluorescence studies. Brain and
kidney tissue were snap-frozen for use as positive controls
in western analyses.
2.2. Preparation of plasma membrane protein samples
Plasma membrane protein samples were prepared from
choroid plexus tissue using a protocol modified from
The´venod et al. [15]. Pooled tissue samples were homoge-
nised in homogenisation buffer (280 mM mannitol, 10 mM
HEPES, 10 mM KCl, 1 mM MgCl2; pH 7.0 with Tris)
supplemented with 1% (v/v) protease inhibitor cocktail
(Sigma). Homogenisation was performed at 4 jC using a
motor-driven glass-in-Teflon homogeniser. The homogenate
was spun at 2500 g for 3 min in a microcentrifuge to
remove unlysed cells, nuclear material and other cell debris.
The supernatant was collected and the pellets were re-
homogenised and re-centrifuged as above. This process
was repeated a total of four times, and the supernatants
were combined to give a post-nuclear supernatant (PNS).
The PNS was then spun at 11,000 g for 20 min at 4 jC.
The pellet (P1), and a sample of the supernatant (S1) were
saved for analysis. The remainder of S1 was then spun at
150,000 g for 1.5 h at 4 jC to yield a plasma membrane
pellet (P2). The supernatant (S2) was saved for analysis,
whilst P2 was resuspended in a minimal volume of homog-
enisation buffer and stored at  80 jC until required. The
protein content of each fraction was determined by the
Bradford method [16], using bovine serum albumin (BSA;
Sigma) as the standard. Western analyses for the a1-subunit
of Na+/K+-ATPase (an apical membrane marker [17]), and
the anion exchanger AE2 (a basolateral membrane marker
[18,19]) were performed on each fraction.
2.3. Western analysis
Protein samples were solubilised in 5 Laemmli sample
buffer (0.32 M Tris (pH 6.8), 5% (w/v) sodium dodecyl
sulfate, 25% (v/v) glycerol, 1% (w/v) bromphenol blue, 5%
(v/v) 2-h-mercaptoethanol) and incubated at 95 jC for 4
min. SDS-PAGE was used to separate proteins, on either
7.5% (AE2), 9% (Na+/K+-ATPase) or 10% (AQP1 and
AQP4) gels. The quantity of protein loaded onto the gels
varied according to the primary antibody used (see figure
legends). Proteins were transferred to polyvinylidene
difluoride membrane (0.2 Am; Bio-Rad Laboratories). After
blocking with Tris-buffered saline-Tween (TBST) contain-
ing 0.1% (v/v) Tween-20 and 3% (w/v) milk for 1 h at room
temperature, the membranes were incubated overnight at 4
jC with one of the following primary antibodies: (i) a
mouse monoclonal to the a1-subunit of Na
+/K+-ATPase
(1:10,000; Upstate Biotech, USA); (ii) an affinity purified
rabbit polyclonal to the COOH-terminal of mouse AE2
(1:10,000; [20]); (iii) an affinity purified rabbit polyclonal
antibody raised against the COOH-terminal of rat AQP1
(1:750; Alpha Diagnostics International, USA); or (iv) an
affinity purified rabbit polyclonal antibody raised against rat
AQP4 (1:250; Alpha Diagnostics International). The mem-
branes were washed in several changes of TBST and
subsequently incubated for 1 h at room temperature with
the secondary antibody (conjugated to horseradish perox-
idase). A rabbit anti-mouse IgG was used with the Na+/K+-
ATPase primary antibody (1:10,000; Jackson Immunore-
search Laboratories, UK), and a donkey anti-rabbit IgG for
AE2, AQP1 and AQP4 (1:10,000; Amersham Pharmacia
Biotech, UK). Additional washing steps in TBST were
followed by antibody detection using ECL-Plus chemilumi-
nescence (Amersham Pharmacia Biotech) according to the
manufacturer’s protocol. Signals were visualised on X-ray
films. Possible non-specific binding of the AE2, AQP1 and
AQP4 primary antibodies was assessed by preadsorbing the
antibody for 1 h with an excess of the respective antigen, i.e.
20:1 for AE2 and 2:1 for AQP1 and AQP4. A crude
homogenate of rat kidney and a membrane fraction from
rat brain (see Alomone Labs Protocol, http://www.alomone.
com) were used as positive controls, in the Western analyses
for AQP1 and AQP4, respectively. All experiments were re-
peated in triplicate.
2.4. Immunofluorescence
Dissected choroid plexus tissue was fixed for 30 min in
either (i) 4% (w/v) paraformaldehyde-PBS or (ii) PLP-
fixative (2% paraformaldehyde, 75 mM lysine, 10 mM
sodium periodate, 37.5 mM Na2HPO4, pH 6.2 [21]). Sec-
tions were subsequently cryoprotected in 30% (w/v) sucrose
for a further 30 min. The tissue was embedded in optimum
cutting texture compound (R.A. Lamb Ltd., UK) and snap-
frozen in N-methylbutane cooled on dry ice. Serial 4 Am
frozen sections were cut using a Leica CM3050 cryostat
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(Leica Instruments, Germany) and thaw-mounted onto gel-
atin-coated glass slides. In one set of control experiments,
AQP4 expression was assessed in sections (4 Am, fixed in
4% paraformaldehyde-PBS) of rat kidney medulla, which
were provided by Dr. Cally Ferguson (University of Man-
chester).
For localisation of AQP1 and AQP4, paraformaldehyde-
fixed sections were rehydrated in PBS for 5 min, and then
blocked with PBS containing 5% (w/v) normal goat serum
and 1% (w/v) BSA for 30 min. The blocking solution was
removed and replaced with either AQP1 (1:500) or AQP4
(1:500) diluted in the blocking solution, and the slides were
then incubated overnight at 4 jC. The slides were washed
twice in high-salt PBS (2.8% (w/v) NaCl), followed by two
washes with PBS and subsequently incubated with a goat
anti-rabbit secondary antibody conjugated to Cy3 (1:400;
Jackson Immunoresearch Laboratories) for 1 h at room
temperature in the dark. The secondary antibody was diluted
in PBS containing 5% normal goat serum and 1% BSA.
Sections were then washed twice for 5 min in high-salt PBS
followed by two washes in PBS, and mounted using
Vectashield (Vector Laboratories Ltd., UK).
The AE2 antibody was used to demonstrate protein
localisation at the basolateral membrane. Following rehy-
dration of PLP-fixed sections in PBS, sections were treated
with 1% SDS in PBS for 5 min. After washing with PBS,
sections were blocked with 1% BSA in PBS and then
incubated overnight at 4 jC with AE2 (1:1,000) diluted in
PBS. The slides were washed three times in PBS and next
incubated with goat anti-rabbit secondary antibody conju-
gated to fluorescent Cy3 (1:400) for 1 h at room temperature
in the dark.
Immunofluorescence was visualised using a Zeiss Axio-
plan 2 microscope. Images were acquired using a Hama-
matsu digital camera and processed using a KS300
software package (Version 3.0; Carl Zeiss, Germany). Non-
specific immunoreactivity was assessed by preadsorbing the
primary antibody with an excess of the peptide antigen (see
above).
Fig. 1. Immunoblot analysis of fourth ventricle choroid plexus protein
fractions for: (A) Na+/K+-ATPase or (B) AE2. Protein fractions (A, 0.25 Ag;
B, 10 Ag) from each step of the plasma membrane preparation protocol
(PNS, post-nuclear supernatant; S1, 11,000 g supernatant; P1, 11,000 g
pellet; S2, 150,000 g supernatant; and P2, 150,000 g pellet), were
separated by SDS-PAGE. Immunoblotting was then performed with either:
(A) the anti-a1-subunit of Na
+/K+-ATPase (0.1 Ag/ml); or (B) the anti-AE2
antibody (1:10,000). The specificity of the AE2 antibody binding was
assessed by preadsorbing the antibody with an excess of antigen (+Ag).
The positions of molecular mass markers are shown on the left.
Fig. 2. AQP1 and AQP4 immunoreactivity in plasma membrane fractions
prepared from choroid plexus tissue. Plasma membrane samples (20 Ag)
were separated by SDS-PAGE on a 10% acrylamide gel. (A) AQP1
antiserum identified immunoreactive bands in kidney homogenate (K),
fourth (IV) and lateral (L) ventricle choroid plexus plasma membrane
fractions. (B) Anti-AQP4 antibodies detected a band in brain (B), fourth
(IV) and lateral (L) ventricle choroid plexus plasma membrane fractions.
Antibody specificity was determined by incubation of the fourth ventricle
sample with the antibody preadsorbed with the antigen (+Ag). The
positions of the molecular mass markers are shown on the left.
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3. Results
3.1. Plasma membrane preparation for western analysis
A method was developed for the isolation of a membrane
fraction from the choroid plexus epithelium. The protein
content of each stage of the preparation (PNS, S1, P1, S2 and
P2) was investigated by western analysis. Fig. 1A shows that
the Na+/K+-ATPase antibody detected two bands of between
90 and 105 kDa, in all samples from fourth ventricle choroid
plexus tissue with the exception of S2. The expected molec-
ular mass of the a1 subunit in the choroid plexus is about 104
kDa [22]. The intensity of the bands appeared to be greatest
in P2 suggesting that this fraction is enriched in apical
Fig. 3. Immunocytochemical localisation of AQP1 and AQP4 in rat choroid plexus. (A) AQP1 is expressed in the apical membrane of: (i) fourth and (ii) lateral
ventricle choroid plexus (arrows indicate the apical membrane); (iii) immunofluorescence from fourth ventricle choroid plexus with AQP1 antibody
preadsorbed with an excess of antigen. (B) AQP4 is diffusely expressed in choroid plexus epithelium cells from the (i) fourth and (ii) lateral ventricles; (iii)
fourth ventricle choroid plexus with the preadsorbed antibody. (C) (i) Discrete staining of the basolateral membrane of rat kidney collecting duct cells with the
AQP4 antibody; (ii) AE2 immunofluorescence of the basolateral membrane (arrows) of fourth ventricle choroid plexus; (iii) AE2 immunofluorescence from
fourth ventricle choroid plexus with the preadsorbed antibody. In each panel the bar = 20 Am.
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membrane proteins. Similar data were obtained with lateral
ventricle choroid plexus (data not shown).
Fig. 1B shows a western blot of protein samples prepared
from fourth ventricle choroid plexus tissue, probed with the
AE2 antibody. This antibody recognised major bands at
f 70, f 95, 140 and f 165 kDa, in the PNS, S1 and P2
fractions. Similar results were obtained with the lateral
ventricle choroid plexus tissue (data not shown). All of
these bands were abolished when the antibody was pread-
sorbed with the peptide antigen (Fig. 1B; + Ag). The
expected molecular mass for AE2 is 165 kDa, however,
the detection of multiple bands by this AE2 antibody has
previously been reported in salivary gland cells [23]. The
strongest staining is seen in P2, suggesting that this fraction
is also enriched for basolateral membrane proteins from the
choroid plexus epithelium.
3.2. Expression of AQP1 and AQP4 by western analysis
Antibodies raised against the COOH-terminus of rat
AQP1 and AQP4 were used to determine the expression
of these proteins in choroid plexus plasma membrane
fractions. The anti-AQP1 identified two bands, of approx-
imately 27 and 32 kDa, in fourth (IV) and lateral (L)
ventricle choroid plexus (Fig. 2A). Bands of similar molec-
ular masses were also observed in the kidney homogenate
sample (K), which was included as a positive control.
Neither band was detected in the fourth ventricle (Fig. 2A;
+Ag) or kidney sample (data not shown), when the primary
antibody had been preadsorbed with an excess of the AQP1
antigen. Fig. 2B shows that the AQP4 antibody detected a
single protein band of 29 kDa, in the fourth (IV) and lateral
(L) ventricle choroid plexuses. A band with a similar
molecular mass was also observed in brain (B), the positive
control tissue. The 29 kDa band was not observed in the
fourth ventricle (Fig. 2B; +Ag) or brain sample (data not
shown), if the antiserum had been preadsorbed with an
excess of the immunizing peptide.
3.3. Localisation of AQP1 and AQP4 by immunofluor-
escence
Immunocytochemical methods were used to determine
the localisation of AQP1 and AQP4 within the choroid
plexus epithelium. In Fig. 3A, sections of (i) fourth and (ii)
lateral ventricle choroid plexus have been probed with anti-
AQP1. Distinct fluorescence was observed in the apical
membrane of the epithelium in both tissues (arrows). AQP1
did not appear to be expressed in the basolateral membrane
of the epithelium, or elsewhere in the choroid plexus. Fig.
3A (iii) shows that when the primary antibody was pre-
adsorbed with an excess of the antigen, there was very little
non-specific binding of either the primary or secondary
antibody in the fourth ventricle choroid plexus sections
(similar data were obtained with the lateral ventricle, data
not shown).
Fig. 3B shows AQP4 expression in (i) fourth and (ii)
lateral ventricle choroid plexus epithelium. The immuno-
fluorescence was diffusely distributed throughout the epi-
thelial cells in both tissues. This diffuse fluorescence was
not a result of non-specific binding of the primary antibody,
because it was not observed when the primary antibody was
preadsorbed with an excess of antigen in the fourth ventricle
(Fig. 3B (iii)) or lateral ventricle (data not shown). Fig. 3C
(i) shows sections of rat kidney medulla probed with the
AQP4 antibody. A distinct pattern of fluorescence is
observed in the basolateral membrane of the collecting duct
epithelium. The AE2 antibody was used in further control
experiments to demonstrate the position of the basolateral
membrane in choroid plexus sections. Fig. 3C (ii) shows the
AE2 localisation in the basolateral membrane (arrows) of
fourth ventricle choroid plexus. No significant fluorescence
was observed in sections incubated with peptide-adsorbed
antibody (Fig. 3C (iii)). Similar patterns of AE2 expression
were observed in the lateral ventricle choroid plexus (data
not shown).
4. Discussion
In this study, we tested the hypothesis that AQP4 is
expressed in the basolateral membrane of rat choroid plexus.
AQP4 expression was investigated initially using western
analysis, and it was necessary to ensure that the protein
sample under examination contained basolateral membrane
proteins. Experiments were therefore performed to show
that the membrane fraction used in the western analysis,
contained marker enzymes for both the apical membrane
(Na+/K+-ATPase) and basolateral membrane (AE2). Both
proteins were detected in the P2 membrane fraction (Fig. 1),
and there appeared to be an enrichment of Na+/K+-ATPase
and AE2 in this fraction compared to the PNS (Fig. 1).
Thus, the membrane fraction contains both apical and
basolateral membrane proteins from the choroid plexus
epithelium. In previous studies of choroid plexus, western
analysis has only been used to study the expression of apical
membrane proteins [5,24–26]. Thus, the identification of
basolateral membrane proteins by western analysis is a
useful development in the study of choroid plexus protein
expression.
AQP1 was detected by western analysis of the P2 frac-
tion. Two peptides of f 27 and f 32 kDa were identified,
and these molecular masses correspond with those of the
unglycosylated and glycosylated form of the AQP1 protein
[5]. Using immunocytochemical methods, AQP1 was found
to be expressed almost exclusively in the apical membrane
of the fourth ventricle and lateral ventricle choroid plexus
(Fig. 3A). These data therefore confirm those of previous
studies of AQP1 expression [5–7].
A single protein band was identified in the western blots
for AQP4 in fourth ventricle choroid plexus, lateral ventricle
choroid plexus and brain (Fig. 2B). These bands were not
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detected when the primary antibody had been preadsorbed
with an excess of antigen, indicating that the antibody was
interacting specifically with the protein. Furthermore, the
molecular mass of the protein detected by the antibody (29
kDa), was similar to that previously reported for AQP4
[8,27,28]. No bands were observed between 30 and 35 kDa
in the present study, which is in contrast to some [12,28,29],
but not all [8,11,27], previous studies of AQP4 expression.
The western analysis data therefore suggest that AQP4
protein is expressed in choroid plexus tissue from the fourth
and lateral ventricle.
Immunocytochemical methods were employed to exam-
ine the localisation of AQP4 within the choroid plexus.
Diffuse immunofluorescence was detected in the epithelial
cells, which was not associated specifically with either the
apical or basolateral membranes (Fig. 3B). This pattern of
fluorescence was clearly very different to that for AQP1,
strongly suggesting that AQP4 is not expressed in the apical
membrane. However, it was possible that the diffuse stain-
ing could be associated with protein expression in the
basolateral membrane, which in the choroid plexus is less
well defined than the apical membrane [1]. Immunocyto-
chemistry was therefore used to examine the expression of
AE2 (the basolateral membrane marker) in the choroid
plexus epithelium. Fig. 3C (ii) shows that both the lateral
and basal parts of the basolateral membranes were clearly
labelled with the AE2 antibody. Similar patterns of staining
have previously been reported for other basolateral trans-
porters, e.g. KCC3 [30]. Other controls were performed to
demonstrate that the lack of membrane labelling was not
due to inadequacies of the AQP4 antibody used in the
present study, i.e. specific labelling of the basolateral
membrane of the kidney collecting duct was observed
(Fig. 3C (i)), as previously reported [29]. These data suggest
that AQP4 is neither expressed in the apical membrane nor
the basolateral membrane of choroid plexus epithelial cells.
The diffuse distribution of AQP4 in the choroid plexus
cells indicates the possible expression of the protein in the
membranes of intracellular organelles. If expressed in organ-
elles, AQP4 could still have been detected in the western
blot, if the membrane fraction contains organellar mem-
branes in addition to the apical and basolateral membranes.
Little is known about AQP4 expression in intracellular
organelles. Nielsen et al. [12], however, did observe AQP4
expression in a membrane fraction prepared from rat cer-
ebellum which was enriched for intracellular organelles. By
contrast, AQP6 and AQP8 are known to be expressed in the
intracellular organelles of kidney tubule cells [3], and the
epithelial cells of the kidney and G.I. tract [31], respectively.
AQP6 has been suggested to have a role in the acidification
of intracellular vesicles in the kidney, a function that is
related more to the permeability of AQP6 to anions than to
water [3]. By contrast, AQP8 has been suggested to ensure
the rapid osmoequilibration between cytoplasmic and vesic-
ular compartments [31]. A similar role can be envisaged for
AQP4 in the choroid plexus epithelial cells.
The demonstration that neither AQP1 nor AQP4 is
expressed in the basolateral membrane means that the route
by which water crosses this membrane remains to be deter-
mined. It is possible that aquaporins other than AQP1 or
AQP4 contribute, however, to date there are no reports of the
expression of other aquaporins in the choroid plexus. Another
possibility is that water crosses the basolateral membrane
coupled to the transport of ions or nutrients. Recent work has
shown that a variety of solute transporters may mediate water
transport [32]. Several of the original observations in support
of this hypothesis were made by Zeuthen [33] who reported
water transport via K+-Cl cotransporters in the apical
membrane of amphibian choroid plexus. These data have
not been confirmed for mammalian choroid plexus, but it is
interesting to note that KCC3 (the only K+-Cl transporter
identified so far in mammalian choroid plexus) is expressed
in the basolateral membrane [30].
In conclusion, AQP1 and AQP4 were identified in west-
ern analysis of rat choroid plexus. AQP1 was expressed
exclusively in the apical membrane, whilst AQP4 was
expressed throughout the cytoplasm of the choroid plexus
epithelial cells. The route by which water crosses the baso-
lateral membrane during CSF secretion therefore remains
unknown.
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